Senior insider sale
SVP, Chief Legal Officer at AMNEAL PHARMACEUTICALS, INC. — senior position signals high conviction
$3.65M
210K shares
What this filing means
DALY JASON B. plans to sell 210K shares of AMNEAL PHARMACEUTICALS, INC. valued at approximately $3.65M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/12/2026ACC: 0001628280-26-056196
Officer· SVP, Chief Legal Officer
Since Jan 2022
210K
Shares to sell
$3.65M
Approx. market value
210K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
EQUITY COMPENSATION
EQUITY COMPENSATION
3/3/2026
210KTotal acquired210K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | EQUITY COMPENSATION EQUITY COMPENSATION | 210K | — |
| Total | 210K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
210K
Market value
$3.65M
8/11/2026
Total
Units
210K
Value
$3.65M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/11/2026 | 210K | $3.65M | NASDAQ | Planned |
| Total | 210K | $3.65M | ||